| Product Name | MF | CAS | Details |
|---|
| MT ND2 antibody | Details |
| 1-aza-2-(3,4-dimethylphenyl)-2-phenylvinyl thiophene-2-carboxylate | C20H17NO2S | 1025576-93-5 | Details |
| tert-Butyl 5-methyl-2-oxo-2,3-dihydro-1H-imidazole-4-carboxylate | C9H14N2O3 | 87214-68-4 | Details |
| Benzoylecgonine-HRP | Details |
| 3-Methyl-1-(phenylsulfanyl)butan-2-ol | C11H16OS | 343331-59-9 | Details |
| 4-Bromo-5-methyl-1,2-thiazole | C4H4BrNS | 1547081-09-3 | Details |
| Big Endothelin-3 (Human, 22-41 Amide) Antiserum | Details |
| 2,2'-Diiodobiphenyl | C12H8I2 | 2236-52-4 | Details |
| Isofuranodiene | C15H20O | 57566-47-9 | Details |
| 3-[(2-Aminophenyl)sulfanyl]propanamide | C9H12N2OS | 98898-02-3 | Details |
| Dimoxystrobin | C19H22N2O3 | 149961-52-4 | Details |
| 4-Formyl-3-methoxy-phenyloxymethyl polystyrene resin (200-400 mesh) | Details |
| 2-Aminomethylquinoline 2HCl | C10H11ClN2 | 18004-62-1 | Details |
| Boc-Thr(Bzl)-PAM resin (200-400 mesh) | Details |
| α-Endorphin | C77H120N18O26S | 59004-96-5 | Details |
| 1-Bromo-2,2-dimethoxypropane | C5H11BrO2 | 126-38-5 | Details |
| SRP14 antibody | Details |
| H-KEVNSQLSL-OH | Details |
| 6-Bromo-5-fluoropyridin-3-ol | C5H3BrFNO | 1211578-32-3 | Details |
| 6-Bromo-1-hydroxypyrene | C16H9BrO | 114562-65-1 | Details |
| Methyl 3-(acetylsulfanyl)-2-chloropropanoate | C6H9ClO3S | 32371-92-9 | Details |
| 3-Chloro-2-fluoropyridin-4-amine hydrochloride | C5H5Cl2FN2 | 2059937-88-9 | Details |
| H-NFMESLPRLGMH-NH2 | Details |
| 2'-O-(2-Methoxyethyl)cytidine | C12H19N3O6 | 223777-16-0 | Details |
| CH 7057288 | C32H31N3O5S | 2095616-82-1 | Details |
| Emicoron | C52H58N6O4 | 1422423-23-1 | Details |
| {[2-(Benzyloxy)-3-bromophenyl]methyl}(methyl)amine hydrochloride | C15H17BrClNO | 1375474-32-0 | Details |
| 1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethanesulfonyl-b-D-mannopyranose | C15H19F3O12S | 92051-23-5 | Details |
| 2-(Difluoromethoxy)pyridin-4-ol | C6H5F2NO2 | 205043-09-0 | Details |
| 2-(5-Amino-1H-indol-3-yl)acetonitrile | C10H9N3 | 26405-47-0 | Details |
| 6-Chloro-2,4-dimethyl-3-nitropyridine | C7H7ClN2O2 | 89793-08-8 | Details |
| GSK-843 | C19H15N5S2 | 1601496-05-2 | Details |
| (Ala2)-Leu-Enkephalin | C29H39N5O7 | 60284-47-1 | Details |
| Octahydropiperazino[1,2-c][1,3]oxazin-6-one hydrochloride | C7H13ClN2O2 | 1423027-53-5 | Details |
| D-Galactosamine hydrochloride - Synthetic origin | C6H14ClNO5 | 1772-03-8 | Details |
| 6-Methoxybenzofuran-2-carbaldehyde | C10H8O3 | 53860-74-5 | Details |
| Syrosingopine - Bio-X ? | C35H42N2O11 | 84-36-6 | Details |
| 1-O-tert-Butyldiphenysilyl-2-azido-4,6-O-benzylidene-2-deoxy-b-D-galactopyranoside | C29H33N3O5Si | 132183-16-5 | Details |
| 5-Amino-pentanamide Hydrochloride | C5H13ClN2O | 97965-80-5 | Details |
| 1-(2-Aminophenyl)imidazolidin-2-one | C9H11N3O | 946386-18-1 | Details |
| 3-(2-Ethoxyphenoxy)propanoic acid | C11H14O4 | 379254-66-7 | Details |
| [Sar1,Ile8]-Angiotensin II | C46H73N13O10 | 37827-06-8 | Details |
| (3-Chlorocyclobutyl)methanamine hydrochlorides | 2287345-32-6 | Details |
| tert-Butyl 3a-(aminomethyl)-octahydro-1H-indole-1-carboxylate | C14H26N2O2 | 2138231-04-4 | Details |
| Recombinant Human Nanog | Details |
| 3-(Hydroxymethyl)-N,N-dimethylbenzene-1-sulfonamide | C9H13NO3S | 951625-83-5 | Details |
| [2-(Azetidin-3-yl)ethyl]dimethylamine dihydrochloride | C7H17ClN2 | 2375269-32-0 | Details |
| 3-Fluorovaline | C5H10FNO2 | 43163-94-6 | Details |
| 1-O-Methyl-beta-D-xylopyranoside | C6H12O5 | 612-05-5 | Details |
| 5-Methylindole-3-carboxaldehyde | C10H9NO | 52562-50-2 | Details |
| 5-(4-Methylcyclohexyl)-1,3-thiazol-2-amine hydrochloride | C10H17ClN2S | 2137573-36-3 | Details |
| 2-Bromo-6-fluoro-5-(trimethylsilyl)pyridine-3-carboxylic acid | C9H11BrFNO2Si | 2089277-02-9 | Details |
| 2-Methoxyethyl 2-chloropyridine-4-carboxylate | C9H10ClNO3 | 1339933-06-0 | Details |
| 4-Methylumbelliferyl N-acetyl-4,7,8,9-tetra-O-acetyl-a-D-neuraminic acid methyl ester | C30H35NO15 | 59361-08-9 | Details |
| (4,4-Dimethylpyrrolidin-3-yl)methanol hydrochloride | C7H15NO.ClH | 2375262-34-1 | Details |
| 4-pyrimidin-2-ylpiperazinyl 3-(trifluoromethyl)phenyl ketone | C16H15F3N4O | 849483-26-7 | Details |
| 2-[2-(Propan-2-yl)-1H-imidazol-1-yl]ethan-1-amine trihydrochloride | C8H16ClN3 | 2137614-62-9 | Details |
| DGCR2 antibody | Details |
| 3-Chloro-5-hydroxybenzoic acid ethyl ester | Details |
| Methyl 7-nitro-1,4-benzodioxane-6-carboxylate | C10H9NO6 | 52791-03-4 | Details |
| Methyl N-(4-amino-2-fluorophenyl)carbamate | C8H9FN2O2 | 1094107-83-1 | Details |
| (Lys8-psi(CH2NH)Lys9)-Neurotensin (8-13) | C38H66N8O7 | 139026-66-7 | Details |
| PLMN antibody | Details |
| H-CSVTCG-OH | Details |
| ethyl 2-nitrilo-3-((3-(1,1,2,2-tetrafluoroethoxy)phenyl)amino)prop-2-enoate | C14H12F4N2O3 | 1025800-09-2 | Details |
| 2-(1H-Imidazol-2-yl)-1-(3-methylphenyl)ethan-1-one hydrochloride | C12H13ClN2O | 1197539-31-3 | Details |
| rac-2,2,2-Trifluoro-N-[(2R,3R)-2-methylpiperidin-3-yl]acetamide | C8H13F3N2O | 1909293-95-3 | Details |
| [1-(Cyclopropylmethyl)cyclopropyl]methanol | C8H14O | 2229149-23-7 | Details |
| 1-(3,5-Dichloropyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid | C10H4Cl2F3N3O2 | 1265323-91-8 | Details |
| 3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-5-methanesulfonylbenzoic acid | 2243513-66-6 | Details |
| Methyl(2-methylbutyl)amine hydrochloride | C6H16ClN | 130985-79-4 | Details |
| 1H-Pyrazolo[3,4-c]pyridine-4-carboxylic acid | C7H5N3O2 | 1260672-64-7 | Details |
| IgG2b Isotype Control Fc fusion protein (PE) | Details |
| PRDX5 antibody | Details |
| 4-?(2,?2-?Dioxido-?2,?1,?3-?benzothiadiazol-?1(3H)?-?yl)?-?1-?piperidinecarboxylic acid 1,?1-?dimethylethyl ester | C16H23N3O4S | 473871-19-1 | Details |
| H-WQQGNVFSCSVMHEALHNHYTQK-OH | Details |
| 3-Methoxypentane-2,4-dione | C6H10O3 | 26213-42-3 | Details |
| Aldol??455 alpha-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 | Details |
| 1-((3,4-dimethoxyphenyl)methyl)-2,6,6-trimethyl-5,6,7-trihydroindol-4-one | C20H25NO3 | 1022427-22-0 | Details |
| 3-Ethyl-5-(2,2,2-trifluoroethyl)-1H-1,2,4-triazole | C6H8F3N3 | 1248135-05-8 | Details |
| 2,2,2-Trifluoro-1-[4-fluoro-3-(trifluoromethyl)phenyl]ethan-1-one | C9H3F7O | 1335013-55-2 | Details |
| 1-(Chloromethyl)-2-ethoxybenzene | C9H11ClO | 60906-78-7 | Details |
| Fmoc-D-Asn(Mtt)-OH | C39H34N2O5 | 200259-50-3 | Details |
| FGF12 protein (His tag) | Details |
| 2-(1-Methyl-1H-pyrazol-4-yl)pyrimidine-5-carbaldehyde | C9H8N4O | 1484524-86-8 | Details |
| 1-[3-(1H-Imidazol-1-yl)propyl]imidazolidine-2,4,5-trione hydrochloride | C9H11ClN4O3 | 1394703-37-7 | Details |
| HAGHL antibody | Details |
| Salicylic acid acyl glucoside | C13H16O8 | 60517-74-0 | Details |
| 2,3-Dimethoxy-5-methylbenzaldehyde | C10H12O3 | 5701-86-0 | Details |
| 1-Cyclopentyl-3-nitro-1H-pyrazole-5-carboxylic acid | C9H11N3O4 | 1006441-13-9 | Details |
| 3-Methylpentan-3-yl carbamate | C7H15NO2 | 78-28-4 | Details |
| H-ISADAMMQALLGAR-OH | Details |
| SARS-CoV-2 IgG (Low Titer) Positive Human Plasma | Details |
| N,N-Dimethyl-5-azaspiro[3.4]octan-7-amine dihydrochloride | 2247102-00-5 | Details |
| 1-(2-Chloroethoxy)-2-methylcyclohexane | C9H17ClO | 1094273-74-1 | Details |
| (4-(4-fluorophenyl)piperazinyl)-N-(4-(trifluoromethoxy)phenyl)formamide | C18H17F4N3O2 | 497060-78-3 | Details |
| Acridine-9-carbonitrile | C14H8N2 | 5326-19-2 | Details |
| Panaxydiol | C17H24O2 | 63910-76-9 | Details |
| 2-nitro-3-((3-nitrophenyl)amino)cyclohex-2-en-1-one | C12H11N3O5 | 1119391-67-1 | Details |
| 6-Bromo-2,2-dimethyl-2H-chromene | C11H11BrO | 82305-04-2 | Details |
| Product Total： Product Page： | ||||
| 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 | ||||